{"url_path":"/sec/usaq/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-022888-index.html","accession_number":"0001493152-26-022888","cik":"0000856984","ticker":"USAQ","issuer_name":"QHSLab, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/856984/0001493152-26-022888-index.html","primary_entity_key":"0000856984","primary_entity_name":"QHSLab, Inc."},"word_count":830,"has_tables":true,"body_markdown":"false\nQ1\n--12-31\n0000856984\n\n0000856984\n\n2026-01-01\n2026-03-31\n\n0000856984\n\n2026-05-14\n\n0000856984\n\n2026-03-31\n\n0000856984\n\n2025-12-31\n\n0000856984\n\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:SeriesAPreferredStockMember\n\n2025-12-31\n\n0000856984\n\nUSAQ:SeriesATwoPreferredStockMember\n\n2026-03-31\n\n0000856984\n\nUSAQ:SeriesATwoPreferredStockMember\n\n2025-12-31\n\n0000856984\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesAPreferredStockMember\n\n2024-12-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nUSAQ:SeriesATwoPreferredStockMember\n\n2024-12-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0000856984\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0000856984\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0000856984\n\n2024-12-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesAPreferredStockMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nUSAQ:SeriesATwoPreferredStockMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesAPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nUSAQ:SeriesATwoPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nUSAQ:SeriesATwoPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesAPreferredStockMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nUSAQ:SeriesATwoPreferredStockMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0000856984\n\n2025-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesAPreferredStockMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:PreferredStockMember\nUSAQ:SeriesATwoPreferredStockMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0000856984\n\n2025-01-01\n2025-12-31\n\n0000856984\n\nus-gaap:RevenueFromContractWithCustomerMember\nus-gaap:CustomerConcentrationRiskMember\nUSAQ:NoCustomerMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:RevenueFromContractWithCustomerMember\nus-gaap:CustomerConcentrationRiskMember\nUSAQ:OneCustomerMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:RevenueFromContractWithCustomerMember\nus-gaap:CustomerConcentrationRiskMember\nUSAQ:OneCustomerMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\nUSAQ:CustomerOneMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\nUSAQ:CustomerOneMember\n\n2025-01-01\n2025-12-31\n\n0000856984\n\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\nUSAQ:CustomerTwoMember\n\n2025-01-01\n2025-12-31\n\n0000856984\n\nus-gaap:PatentsMember\n\n2026-03-31\n\n0000856984\n\nUSAQ:WebDomainMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:TrademarksMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:AllergyDiagnosticKitSalesMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:AllergyDiagnosticKitSalesMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:IntegratedServiceProgramMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:IntegratedServiceProgramMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:ImmunotherapyTreatmentSalesMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:ImmunotherapyTreatmentSalesMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:ClinicalStudyRevenueMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:ClinicalStudyRevenueMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:SubscriptionRevenueMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:SubscriptionRevenueMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:ShippingAndHandlingMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:ShippingAndHandlingMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:TrainingAndOtherRevenueMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:TrainingAndOtherRevenueMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:SoftwareAndSoftwareDevelopmentCostsMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:PatentsMember\n\n2025-12-31\n\n0000856984\n\nUSAQ:WebDomainMember\n\n2026-03-31\n\n0000856984\n\nUSAQ:WebDomainMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:TrademarksMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:TrademarksMember\n\n2025-12-31\n\n0000856984\n\nUSAQ:MedScienceResearchGroupMember\n\n2021-06-23\n2021-06-23\n\n0000856984\n\n2025-11-12\n2025-11-12\n\n0000856984\n\nUSAQ:ConvertibleNotesPayableOneMember\nUSAQ:NoteOneShareholderMember\n\n2026-03-31\n\n0000856984\n\nUSAQ:ConvertibleNotesPayableOneMember\nUSAQ:NoteOneShareholderMember\n\n2025-12-31\n\n0000856984\n\nus-gaap:ConvertibleNotesPayableMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:ConvertibleNotesPayableMember\n\n2025-12-31\n\n0000856984\n\nUSAQ:ConvertibleNotesPayableOneMember\n\n2021-05-07\n\n0000856984\n\nUSAQ:ConvertibleNotesPayableOneMember\nUSAQ:NoteOneShareholderMember\n\n2021-05-07\n\n0000856984\n\nUSAQ:ConvertibleNotesPayableOneMember\nUSAQ:NoteOneShareholderMember\n\n2021-05-07\n2021-05-07\n\n0000856984\n\nUSAQ:SubscriptionAgreementsMember\nus-gaap:PrivatePlacementMember\n\n2025-12-26\n2025-12-26\n\n0000856984\n\nUSAQ:SubscriptionAgreementsMember\nus-gaap:PrivatePlacementMember\n\n2025-12-26\n\n0000856984\n\nus-gaap:SeriesAPreferredStockMember\n\n2021-06-21\n\n0000856984\n\nUSAQ:SeriesA2PreferredStockMember\n\n2021-12-29\n2021-12-30\n\n0000856984\n\nUSAQ:SeriesA2PreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:SeriesA2PreferredStockMember\n\n2025-01-01\n2025-12-31\n\n0000856984\n\nUSAQ:CommonEquivalentSharesMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:CommonEquivalentSharesMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-12-31\n\n0000856984\n\nus-gaap:CommonStockMember\n\n2024-01-01\n2024-12-31\n\n0000856984\n\nUSAQ:ResearchAndDevelopmentExpensesMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:ResearchAndDevelopmentExpensesMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:GeneralAndAdministrativeExpensesMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:GeneralAndAdministrativeExpensesMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:OptionOneMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:OptionOneMember\n\n2025-03-31\n\n0000856984\n\nUSAQ:OptionTwoMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:OptionTwoMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:OptionMember\n\n2025-03-31\n\n0000856984\n\nUSAQ:WarrantOneMember\n\n2026-01-01\n2026-03-31\n\n0000856984\n\nUSAQ:WarrantOneMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0000856984\n\nUSAQ:WarrantOneMember\n\n2025-01-01\n2025-03-31\n\n0000856984\n\nUSAQ:WarrantOneMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:WarrantMember\n\n2025-03-31\n\n0000856984\n\nus-gaap:RelatedPartyMember\n\n2026-03-31\n\n0000856984\n\nus-gaap:RelatedPartyMember\n\n2025-12-31\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n**FORM\n10-Q**\n\n \n\n**☒\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nFor\nthe quarterly period ended March 31, 2026\n\n \n\n☐\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor\nthe period from ______________ to_______________\n\n \n\nCommission\nfile number 000-19041\n\n \n\n**QHSLab,\nInc.**\n\n(Exact\nName Of Registrant As Specified In Its Charter)\n\n \n\nNevada\n \n30-1104301\n\n(State\nof\n\nIncorporation)\n\n \n\n(I.R.S.\nEmployer\n\nIdentification\nNo.)\n\n \n\n901\nNorthpoint Parkway, Suite 302, West Palm Beach, FL\n\n \n33407\n\n(Address\nof Principal Executive Offices)\n \n(ZIP\nCode)\n\n \n\nRegistrant’s\nTelephone Number, Including Area Code: (929) 379-6503\n\n \n\n**Securities\nRegistered Pursuant to Section 12(g) of The Act:**\n\n \n\n**Title\nof Each Class**\n \n**Trading\nSymbol(s)**\n \n**Name\nof each Exchange on Which Registered**\n\n**Common\nStock, $0.0001 Par Value**\n \n**USAQ**\n \n**NA**\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange\nAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)\nhas been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule\n405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant\nwas required to submit such files). Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting\ncompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”\n“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\n \nLarge\naccelerated filer ☐\nAccelerated\nfiler ☐\n \n\n \nNon-accelerated\nfiler ☒\nSmaller\nReporting Company ☒\n \n\n \n \nEmerging\nGrowth Company ☐\n \n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nOn\nMay 14, 2026, the Registrant had 15,032,788 shares of common stock outstanding.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**TABLE\nOF CONTENTS**\n\n \n\n**Item**\n \n**Description**\n \n**Page**\n\n \n \n \n \n \n\n \n \n**PART I - FINANCIAL INFORMATION**"}